🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Charles River Laboratories International, Inc.

CRL Healthcare
$150.85 $-8.27 (-5.20%)
Market Cap: $7.27 B
Gurus Holding
7
Popularity Rank
#945
% of Shares Held
4.04%
Net Activity (Q1 2026)
-$37.52 M

Guru Ownership Trend

Guru Analysis for Charles River Laboratories International, Inc. (CRL)

Charles River Laboratories International, Inc. (CRL), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $293.36 M.

Top institutional holders include John Rogers and Joel Greenblatt.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $37.52 M net outflow during the quarter.

Recent activity highlights Louis Moore Bacon who increased their stake by 296.5%. Conversely, Ray Dalio reduced exposure by 69.0%.

Key Holders

Top 5 by Value

$249.12 M
$61.84 M
$11.8 M
$2.1 M

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$21.72 M
Total Buy Value
New Buys 1
Additions 3
-$59.24 M
Total Sell Value
Reductions 3
Sold Out 4

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
7
Net Buyers
4

FAQs for Charles River Laboratories International, Inc. (CRL)

Major holders include John Rogers ($249.12 M), Joel Greenblatt ($61.84 M), Cliff Asness ($11.8 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 1.94 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $37.52 M, with 4 managers increasing positions and 7 managers reducing holdings.

During the most recent reporting period, 3 managers trimmed their positions, while 4 fully exited CRL. The total reported sell value was $59.24 M.

Yes, 1 managers opened new positions in CRL, and 3 increased their existing holdings. The total reported buy value was $21.72 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
2.79% Add 1.2% 1,444,183 $249.12 M Q1 2026
0.19% Add 23.8% 358,502 $61.84 M Q1 2026
0.01% Reduce -40.4% 71,578 $11.8 M Q1 2026
0.15% Add 296.5% 43,234 $7.46 M Q1 2026
0.02% Reduce -3.1% 12,192 $2.1 M Q1 2026
0.02% New Buy 8,178 $1.41 M Q1 2026
0.01% Reduce -69.0% 6,835 $1.18 M Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form